TYK Medicines (HKSE:02410) OCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02410 TYK Medicines Inc HKSE:02410
7 GF Score
Price HK$6.81
! 3 Warning Signs
View Full Analysis

What is TYK Medicines OCF Margin %?

TYK Medicines HKSE:02410 -4.08% 7 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review. Among 952 Biotechnology companies, TYK Medicines ranks worse than 105041.91% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. TYK Medicines's Cash Flow from Operations for the six months ended in Dec. 2025 was HK$-134.35 Mil. TYK Medicines's Revenue for the six months ended in Dec. 2025 was HK$0.00 Mil. Therefore, TYK Medicines's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, TYK Medicines's current OCF Yield % is -9.06%.

The historical rank and industry rank for TYK Medicines's OCF Margin % or its related term are showing as below:


During the past 4 years, the highest OCF Margin % of TYK Medicines was -497.38%. The lowest was -288694.74%. And the median was -144596.06%.

HKSE:02410's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -65.71
* Ranked among companies with meaningful OCF Margin % only.

TYK Medicines OCF Margin % Related Terms

TYK Medicines OCF Margin % Historical Data

* Premium members only.

The historical data trend for TYK Medicines's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TYK Medicines OCF Margin % Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24 Dec25
OCF Margin %
-497.38 0.00 -288,694.74 0.00

TYK Medicines Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 -161,060.53 0.00 0.00
HKSE:02410
7GF Score
TYK Medicines Inc HKSE:02410
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TYK Medicines OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

TYK Medicines's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-238.364/0
= %

TYK Medicines's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-134.348/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
TYK Medicines (HKSE:02410) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TYK Medicines and its competitors. According to the industry distribution chart, TYK Medicines ranks #999999 out of 952 companies in the Biotechnology industry.
Is TYK Medicines' OCF Margin % too high?
TYK Medicines' current OCF Margin % is 0.00%. Based on the distribution chart, TYK Medicines ranks #999999 out of 952 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TYK Medicines ranks #999999 out of 952 companies for OCF Margin %. This places TYK Medicines in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TYK Medicines and its competitors. TYK Medicines's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TYK Medicines Business Description

Address No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score

Get the complete analysis for HKSE:02410

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.81
Price